United States · 
What does Mutual Capital Partners invest in?
Mutual Capital Partners invests most often at Series A and Series B (80% of the rounds on record), in sectors such as Connected Health, Connected-health and E-health.
Mutual Capital Partners highlights
- 01
10 rounds on record
- 02
Mostly Series A and Series B: 80% of its rounds
- 03
Sole investor in 4 rounds, median $2.4M
- 04
2 exits from the portfolio
What they do
Mutual Capital Partners is a Cleveland, Ohio venture capital fund that invests in Midwest based early stage software and medical device companies.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Connected HealthConnected-healthE-health
- Based in
- Westlake, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first10 appearances
- 2018
1 round
- Dec
- 2015
1 round
- Jun
- 2013
1 round
- Oct
- 2010
2 rounds
- Apr
- Apr
- 2008
1 round
- Jun
- 2006
2 rounds
- May
- Jan
- 2005
1 round
- Sept
- 2004
1 round
- Sept
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
WWWayne WallaceMr. Wallace is a Managing DirectoriFiling they signed
WTWilliam TrainorMr. Trainor is a Managing DirectoriFiling they signed
We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
12 of 22 we have independently watched raise
CATALYST_LOGO_COLORCheckpoint-Logo-Blue-300x88Coolerheadsbevocalcleveland-heart-labcleveland-heart-labcropped-faviconenosixhereiotamotionorthalignorthalign1200px-Netkey1524240199979.jpgCaptureRediRevLocalRevLocalSprpainreliefSynchronoss -ebluupwork (1)
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
OrthoHelix Surgical DesignsBought by Tornier$135MAug 2012
HemosphereBought by CryoLife$22MMay 2012
An exit counts when it came after the firm's first round in the company. From historical deal records.